Targeting miRNA by CRISPR/Cas in cancer: advantages and challenges.
Hussen BM, Rasul MF, Abdullah SR, Hidayat HJ, Faraj GSH, Ali FA, Salihi A, Baniahmad A, Ghafouri-Fard S, Rahman M, Glassy MC, Branicki W, Taheri M.
Hussen BM, et al. Among authors: salihi a.
Mil Med Res. 2023 Jul 17;10(1):32. doi: 10.1186/s40779-023-00468-6.
Mil Med Res. 2023.
PMID: 37460924
Free PMC article.
Review.